Desk›Healthcare› Parmax Pharma Ltd
Parmax Pharma Ltd
BSE 540359 · NSE PARMAX · ISIN INE240T01014 · Group XT · Suspended
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹131.15
+0.96%
BSE close, 28 August 2026
₹49.07 cr
0.4 cr shares · Micro cap
₹31.33 cr
as published
-41.1× · -485.74×
EPS ₹-3.19 · BV ₹-0.27
12.11 / -4.16
₹ cr, as filed
22
6 selected · 27%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | +0.0% |
|---|---|
| Against 52-week low | +480.3% |
| Day change | +0.96% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-3.19 |
|---|---|
| Price / earnings | -41.11× |
| Price / book | -485.74× |
| Book value — derived, price ÷ P/B | ₹-0.27 |
| Return on equity | 1,202.42% |
| Operating margin | 35.37% |
| Net margin | 26.76% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 1,181.56%
- ROE as published
- 1,202.42%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 8.22 | 2.20 | 5.88 | 35.37% | 26.76% |
| Mar-26 · Q | 3.31 | -0.58 | -1.56 | -46.03% | -17.63% |
| FY25-26 | 12.11 | -4.16 | -11.12 | -29.66% | -34.34% |
Quarter on quarter
- Revenue, quarter on quarter
- +148.3%
- Net profit, quarter on quarter
- +479.3%
- Operating margin, quarter on quarter
- +8,140 bps
Disclosure profile 22 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Open Offer | 2 |
| Board Outcome | 1 |
| Change in Management | 1 |
| Resignation | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| General | 4 |
| AGM / EGM | 3 |
| SAST | 3 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Insider / SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 16 |
| Total | 22 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
22 filings · 6 selected · busiest 2026-08-14
Filing rhythm · the twelve most recent
2026-08-172026-10-08
SelectedProcedural
Filings
22 in the window · 21 earlier on record
-
8 October 2026 ·
Resignation of Director
Resignation of Mr. Nikhil Uchat, an Independent Director of the Company
Company Update / Resignation of Director View filing →
-
1 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting results along with Scrutinizer report
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 32nd Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Closure of Trading Window
Closure of trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
28 September 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015 - Intimation Of Fire Inc ident At The Plant Of The Company
Announcement under regulation 30 of SEBI (LODR) Regulation 2015 - Intimation of Major Fire Inc ident at the plant of the company
Company Update / General View filing →
-
9 September 2026 ·
Newspaper Publication
Newspaper Publication for 32nd Annual general Meeting of the Company
Company Update / Newspaper Publication View filing →
-
7 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report of Financial Year 2025-26 along with Notice of Annual General Meeting
Others / Reg. 34 (1) Annual Report View filing →
-
7 September 2026 ·
Notice Of Annual General Meeting
Notice of Annual General Meeting of Company
AGM/EGM / AGM View filing →
-
2 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Shah & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
24 August 2026 ·
Intimation Of Reclassification Of Promoters Under Regulation 31A Of SEBI (LODR) Regulations, 2015
Intimation of Reclassification of Promoters under Regulations 31A of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
24 August 2026 ·
Post Offer Advertisement
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulations 18(12) of the Securities and Exchange Board of India ....
Company Update / General View filing →
-
17 August 2026 ·
Newspaper Publication
Newspaper publication of extract of Financial results of quarter ended June 30, 2026
Company Update / Newspaper Publication View filing →
-
17 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh Mahasukhlal Gopani & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Change in Management
Appointment of Mr. Dhiren Shah, Mr. Sunil Shah as an Additional Directors and recommendation of Ms. Anjana Shah, Ashish Shah as an Independent Directors subject to prior approval of shareholders ....
Company Update / Change in Management View filing →
-
14 August 2026 ·
Results For Quarter Ended June 30, 2026
Results for quarter ended June 30, 2026
Result / Financial Results View filing →
-
14 August 2026 ·
Board Meeting Outcome for Approval Of Unaudited Financial Results For Quarter Ended 30.06.2026
Outcome of Board Meeting as per attached
Board Meeting / Outcome of Board Meeting View filing →
-
14 August 2026 ·
Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Shah & Others
Insider Trading / SAST / Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011 View filing →
-
11 August 2026 ·
Board Meeting Intimation for Approval Of Quarterly Financial Results For Quarter Ended June 30, 2026
Parmax Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve quarterly financial results for ....
Board Meeting / Board Meeting View filing →
-
29 July 2026 ·
Updates on Open Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma ....
Company Update / Open Offer View filing →
-
27 July 2026 ·
Updates on Open Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors ('IDC') to the Public ....
Company Update / Open Offer View filing →
-
22 July 2026 ·
Letter of Offer
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
Company Update / General View filing →
RSS feed for Parmax Pharma Ltd · the 50 most recent filings